The rate-pressure-time product was taken as the product of heart rate, mean systolic arterial pressure, and left ventricular ejection time (measured from the beginning of the upstroke to the dicrotic notch of the arterial pressure, in msec, recorded at 200 mm/sec).
Results
The results of the initial observations, after 10 min of phentolamine infusion and 1 hour after this infusion had been discontinued are shown in Figure 4 The effects of phentolamine on heart rate, arterial mean pressure, and rate-pressure-time product in the acute and chronic hypertensive patients. The five patients with acute hypertension are denoted by the word ACUTE and the six patients with chronic hypertension by the word CHRONIC.
The bar histogram represents the mean and 1 SD in 11 patients. The cross-hatched columns are the control findings before phentolamine, the open columns after 10 min of phentolamine infusion, and the dotted columns 1 hour after phentolamine was discontinued. Arterial pressure has the same directional change in both groups. Heart rate did not change significantly at 10 min or 1 hour in the acute group. The chronic group had a significant increase in rate (P < 0.05) which persisted for 1 hour. The rate-pressuretime product decreased (P < 0.02) at 10 min and 1 hour in the acute group but remained unchanged in the chronic.
coronary blood flow to an ischemic area. It might well, however, improve flow to the ischemic area of the endocardium by favorably altering intramyocardial pressure, and hence the distribution of Circulation, Volume XLVII, blood flow across the myocardium.'3 As our patients improved hemodynamically the imbalance between oxygen demand and supply in the ischemic myocardium may have been favorably altered even though arterial pressure decreases slightly. Although we did not find relief of chest pain and arrhythmias during vasodilatory therapy in acute myocardial infarction other workers have and they suggested the oxygen supply to the ischemic myocardium may be improved.' While left ventricular function was improved in all patients with hypertension, in some with preexisting chronic hypertension heart rate increased when systemic vascular resistance fell. This is probably secondary to increase baroreceptor activity attempting to maintain the chronically fixed level of hypertension. ' (1) increase oxygen delivery to the ischemic area, (2) reduce overall myocardial oxygen requirements, and (3) result in an improvement in left ventricular function and relieve pulmonary congestion. While none of the currently available pharmacologic approaches to the therapy of left ventricular dysfunction associated with myocardial infarction satisfy all these requirements, phentolamine fulfills the last two of the above criteria and would appear to be worthy of further exploration and clinical application in patients with transient hypertension complicating acute myocardial infarction. In patients with chronic hypertension associated with myocardial infarction the reduction in pulmonary congestion and improved left ventricular function may not, however, be associated with reduced myocardial oxygen consumption due to a compensating increase in heart rate.
